关注
Chris Hemmings
Chris Hemmings
Canterbury Health Laboratories
在 member.rcpa.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis
M Ito, L Barys, T O'Reilly, S Young, B Gorbatcheva, J Monahan, ...
Clinical Cancer Research 17 (3), 416-426, 2011
1322011
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
MJ McCoy, C Hemmings, TJ Miller, SJ Austin, MK Bulsara, N Zeps, ...
British journal of cancer 113 (12), 1677-1686, 2015
792015
The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis
C Hemmings
Pathology 42 (2), 105-112, 2010
472010
The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner
M Baird, PW Ang, I Clark, D Bishop, M Oshima, MC Cook, C Hemmings, ...
Laboratory investigation 93 (1), 112-122, 2013
442013
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
MJ McCoy, C Hemmings, CC Anyaegbu, SJ Austin, TF Lee-Pullen, ...
Oncotarget 8 (12), 19803, 2017
412017
The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3
TJ Miller, MJ McCoy, C Hemmings, MK Bulsara, B Iacopetta, CF Platell
Pathology 49 (7), 721-730, 2017
402017
Universal molecular screening does not effectively detect Lynch syndrome in clinical practice
B Brennan, CT Hemmings, I Clark, D Yip, M Fadia, DR Taupin
Therapeutic advances in gastroenterology 10 (4), 361-371, 2017
322017
Personalising pancreas cancer treatment: when tissue is the issue
KM Sjoquist, VT Chin, LA Chantrill, C O’Connor, C Hemmings, DK Chang, ...
World journal of gastroenterology: WJG 20 (24), 7849, 2014
312014
Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
C Hemmings
Pathology-Journal of the RCPA 45 (4), 371-381, 2013
292013
Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
MJ McCoy, C Hemmings, S Hillery, C Penter, MK Bulsara, N Zeps, ...
ANZ journal of surgery 87 (12), E233-E239, 2017
252017
Thyroid pathology in four patients with Cowden's disease
CT Hemmings
Pathology 35 (4), 311-314, 2003
252003
Pathological grading of regression: an International Study Group perspective
R Chetty, P Gill, AC Bateman, DK Driman, D Govender, AR Bateman, ...
Journal of clinical pathology 65 (10), 865-866, 2012
212012
National Working Group Meeting on ALK diagnostics in lung cancer
W Cooper, S Fox, S O'toole, A Morey, G Frances, N Pavlakis, K O'byrne, ...
Asia‐Pacific Journal of Clinical Oncology 10 (S2), 11-17, 2014
172014
Immunohistochemical expression of EGFR in colorectal carcinoma correlates with high but not low level gene amplification, as demonstrated by CISH
C Hemmings, A Broomfield, E Bean, M Whitehead, D Yip
Pathology 41 (4), 356-360, 2009
172009
Expression of PD‑L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion
TJ Miller, MJ Mccoy, C Hemmings, B Iacopetta, CF Platell
Oncology letters 16 (5), 5761-5768, 2018
162018
Menetrier's disease in a patient with ulcerative colitis: a case report and review of the literature
CT Hemmings
Pathology 39 (2), 282-283, 2007
162007
The changing face of GIST: implications for pathologists
C Hemmings, D Yip
Pathology-Journal of the RCPA 46 (2), 141-148, 2014
152014
Changes in the pathology reporting of rectal cancer: is it time to adopt synoptic reporting?
C Hemmings, M Jeffery, F Frizelle
The New Zealand Medical Journal (Online) 116 (1178), 2003
152003
Neuromuscular and vascular hamartoma arising in a Meckel's diverticulum
CT Hemmings
Pathology 38 (2), 173-174, 2006
142006
Primary omental synovial sarcoma: a case with cytogenetic confirmation
C Hemmings, C Fisher
Pathology 36 (2), 208-211, 2004
142004
系统目前无法执行此操作,请稍后再试。
文章 1–20